V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20224729 | 20132719 | 1.48 | 80.9 | Palliative (P) | 2019-01-30 | 2019-01-31 | null | 02 | N | OXALIPLATIN | 101570767 |
| 20224731 | 20132720 | 1.81 | 75 | null | 2018-08-29 | 2018-10-04 | null | N | null | SCALOP-2 TRIAL | 100976054 |
| 20224732 | 20132721 | 1.63 | 41.2 | Palliative (P) | 2020-05-13 | 2020-05-27 | null | 02 | N | LUTETIUM-177 | 101281448 |
| 20224734 | 20132722 | 1.61 | 125.8 | Palliative (P) | 2021-01-02 | 2021-01-13 | null | 99 | N | EVEROLIMUS | 100902920 |
| 20224737 | 20132723 | 167 | 83.8 | null | null | 2018-08-07 | null | 02 | null | PEMBROLIZUMAB | 100509326 |
| 20224743 | 20132724 | 1.73 | 92 | null | null | 2016-10-28 | null | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100758711 |
| 20224747 | 20132725 | 1.73 | 97.1 | Palliative (P) | null | 2020-01-22 | null | null | N | ENZALUTAMIDE | 100432942 |
| 20224754 | 20132726 | 1.63 | null | Palliative (P) | 2016-10-13 | 2016-10-28 | null | 01 | N | TRIFLURIDINE + TIPIRACIL | 100374985 |
| 20224756 | 20132727 | 1.53 | 71.1 | null | null | 2019-04-30 | null | 02 | null | ENZALUTAMIDE | 101464262 |
| 20224765 | 20132728 | 1.58 | null | Palliative (P) | 2018-01-18 | 2018-02-09 | Sunitinib | null | N | ATEZOLIZUMAB + BEVACIZUMAB | 100439967 |
| 20224768 | 20132729 | null | null | null | null | 2016-12-28 | null | 02 | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100177448 |
| 20224785 | 20132730 | 1.8 | 73.2 | Curative (C) | null | 2018-12-22 | null | N | N | CISPLATIN | 101802050 |
| 20224792 | 20132731 | 1.63 | 0 | null | null | 2017-06-14 | null | N | null | ENZALUTAMIDE | 101433890 |
| 20224803 | 20132732 | 1.74 | 77 | Palliative (P) | 2016-12-09 | 2016-12-15 | null | 2 | N | SCALOP-2 TRIAL | 101861479 |
| 20224810 | 20132733 | 1.61 | 95 | Palliative (P) | null | 2021-08-10 | null | N | N | BEVACIZUMAB | 100372471 |
| 20224829 | 20132734 | 1.73 | 62 | null | null | 2017-10-25 | null | N | null | ENZALUTAMIDE | 100465200 |
| 20224831 | 20132735 | 1.63 | 72.1 | null | null | 2020-01-05 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101076822 |
| 20224846 | 20132736 | 1.76 | 89 | Curative (C) | null | 2016-06-14 | null | 2 | Y | CISPLATIN + ETOPOSIDE | 100037646 |
| 20224856 | 20132737 | 1.7 | 72.1 | Palliative (P) | null | 2014-10-06 | null | N | N | EVEROLIMUS | 101447587 |
| 20224857 | 20132738 | 1.68 | 64.6 | null | 2018-06-12 | 2018-06-28 | null | N | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100499662 |
| 20224861 | 20132739 | 1.95 | 44 | null | 2019-12-12 | 2019-12-17 | null | 2 | null | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101082854 |
| 20224871 | 20132740 | null | 7.1 | null | 2019-06-19 | 2019-06-22 | Sunitinib | 02 | null | SUNITINIB | 101178172 |
| 20224880 | 20132741 | null | null | null | 2019-07-19 | 2019-07-25 | null | N | null | MITOMYCIN INTRAVESICULAR | 101069456 |
| 20224881 | 20132742 | 1.8 | 114 | Palliative (P) | 2019-11-07 | 2019-11-14 | LUTETIUM-177 | null | N | TRIFLURIDINE + TIPIRACIL | 100112695 |
| 20224896 | 20132743 | 1.49 | 66.4 | Palliative (P) | null | 2019-04-02 | LUTETIUM-177 | null | N | OXALIPLATIN | 101860791 |
| 20224907 | 20132744 | 1.68 | 56.9 | null | null | 2016-03-29 | null | N | null | LUTETIUM-177 | 101276066 |
| 20224909 | 20132745 | 1.68 | 90 | Palliative (P) | 2016-01-30 | 2016-04-17 | null | 02 | N | SCALOP-2 TRIAL | 100323608 |
| 20224935 | 20132747 | 1.72 | 76 | Palliative (P) | null | 2016-07-14 | null | 02 | N | BEVACIZUMAB | 100659852 |
| 20224940 | 20132748 | null | null | null | null | 2017-07-23 | null | 02 | null | OCTREOTIDE | 101563740 |
| 20224942 | 20132749 | 1.73 | 85.9 | Palliative (P) | null | 2018-02-13 | null | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100586514 |
| 20224951 | 20132750 | 1.68 | 82 | Curative (C) | null | 2018-09-25 | null | N | Y | LENALIDOMIDE | 100316878 |
| 20224952 | 20132751 | 1.73 | 77.4 | null | 2019-12-22 | 2020-01-02 | null | 02 | null | TRIFLURIDINE + TIPIRACIL | 100571834 |
| 20224959 | 20132752 | 1.59 | 50 | Curative (C) | null | 2018-02-05 | Cetuximab + Encorafenib | N | N | CETUXIMAB + ENCORAFENIB | 101029100 |
| 20224986 | 20132753 | 1.63 | 108.5 | 02 | 2017-04-02 | 2017-04-30 | null | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100551438 |
| 20224996 | 20132754 | 1.57 | 82.2 | Palliative (P) | null | 2016-02-18 | null | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100365035 |
| 20224998 | 20132755 | 1.7 | 57.6 | Curative (C) | 2017-05-13 | 2017-05-15 | null | 99 | Y | LUTETIUM-177 | 100379250 |
| 20225005 | 20132756 | 1.63 | null | Palliative (P) | 2016-10-30 | 2017-01-29 | null | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101010503 |
| 20225022 | 20132757 | 1.82 | 92.3 | null | null | 2017-09-19 | null | 02 | null | CISPLATIN | 101322984 |
| 20225030 | 20132758 | 1.6 | 71 | Palliative (P) | null | 2017-06-29 | null | N | N | ABIRATERONE | 100779774 |
| 20225038 | 20132759 | null | null | Palliative (P) | null | 2016-05-13 | null | N | Y | LENALIDOMIDE | 100569967 |
| 20225047 | 20132760 | 1.65 | 57 | null | null | 2019-03-10 | null | 02 | null | OXALIPLATIN | 101276033 |
| 20225070 | 20132761 | 1.83 | 85.3 | Palliative (P) | 2018-03-18 | 2018-03-25 | null | N | null | CETUXIMAB + ENCORAFENIB | 101155417 |
| 20225077 | 20132762 | 1.8 | 81.6 | null | 2016-12-03 | 2017-01-07 | null | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101043505 |
| 20225079 | 20132763 | 1.5 | 153 | Adjuvant (A) | null | 2017-02-24 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 101572369 |
| 20225081 | 20132764 | 1.82 | 0 | Neo-adjuvant (N) | 2016-11-10 | 2016-12-14 | null | N | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101042380 |
| 20225082 | 20132765 | 1.51 | 60.6 | null | 2020-07-02 | 2020-07-14 | null | 01 | y | MITOMYCIN INTRAVESICULAR | 100306348 |
| 20225094 | 20132766 | 1.7 | 56.2 | null | 2017-06-30 | 2017-07-02 | null | N | null | PEMBROLIZUMAB | 100697439 |
| 20225097 | 20132767 | 1.75 | 50.3 | Adjuvant (A) | 2018-12-16 | 2018-12-20 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101597125 |
| 20225112 | 20132768 | 0 | 99.6 | Palliative (P) | 2020-01-03 | 2020-01-03 | null | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101205185 |
| 20225118 | 20132769 | 1.89 | 60.4 | null | 2016-08-06 | 2016-09-03 | Sunitinib | 02 | null | SUNITINIB | 100545998 |